PLSE
NASDAQ HealthcarePulse Biosciences, Inc - Common Stock
Medical Instruments & Supplies
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
�� 市场数据
| 价格 | $23.40 |
|---|---|
| 成交量 | 249,890 |
| 市值 | 1.59B |
| 贝塔系数 | 1.690 |
| RSI（14日） | 59.6 |
| 200日均线 | $16.85 |
| 50日均线 | $20.91 |
| 52周最高 | $26.30 |
| 52周最低 | $12.56 |
| Forward P/E | -27.21 |
| Price / Book | 19.68 |
🎯 投资策略评分
PLSE 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🚀 Moon Shot (91/100) — 此策略 高增长潜力（高贝塔 + 超卖）.
评分最低的策略： 💰 Dividend Daddy (10/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 PLSE in your text
粘贴任何文章、记录或帖子 — 工具将提取 PLSE 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.